FDA ALERT
FDA ALERT
01/29/2024

Anthony Calabro, MA

Anthony Calabro, MA
The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.
01/29/2024